We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ASRT Assertio Holdings Inc

0.10 (9.8%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,119,852
Bid Price 1.12
Ask Price 1.16
News -
Day High 1.16


52 Week Range


Day Low 1.02
Company Name Stock Ticker Symbol Market Type
Assertio Holdings Inc ASRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 9.8% 1.12 18:39:35
Open Price Low Price High Price Close Price Prev Close
1.03 1.02 1.16 1.14 1.02
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,190 1,119,852 $ 1.12 $ 1,249,861 - 0.87 - 8.01
Last Trade Time Type Quantity Stock Price Currency
19:58:40 1 $ 1.16 USD

Assertio Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
108.87M 94.67M - 156.23M 109.63M 1.16 0.99
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Assertio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ASRT Message Board. Create One! See More Posts on ASRT Message Board See More Message Board Posts

Historical ASRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,208,095-0.12-9.68%
1 Month2.192.370.871.272,279,667-1.07-48.86%
3 Months3.243.270.871.991,681,844-2.12-65.43%
6 Months6.3396.560.873.471,949,526-5.22-82.33%
1 Year3.108.010.874.471,923,796-1.98-63.87%
3 Years0.42138.010.3311.832,984,4940.6987165.84%
5 Years5.0710.050.331.772,300,462-3.95-77.91%

Assertio Description

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |